M

MedPacto Inc
KOSDAQ:235980

Watchlist Manager
MedPacto Inc
KOSDAQ:235980
Watchlist
Price: 5 580 KRW -8.97%
Market Cap: 191.3B KRW

Operating Margin

-643.7%
Current
Improving
by 1 154.5%
vs 3-y average of -1 798.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-643.7%
=
Operating Income
₩-15.9B
/
Revenue
₩2.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-643.7%
=
Operating Income
₩-15.9B
/
Revenue
₩2.5B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
MedPacto Inc
KOSDAQ:235980
191.3B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
382B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
160.4B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.2B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.6B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.2B USD
Loading...
No Stocks Found

Market Distribution

Lower than 99% of companies in Korea
Percentile
1st
Based on 2 615 companies
1st percentile
-643.7%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

MedPacto Inc
Glance View

Market Cap
191.3B KRW
Industry
Biotechnology

MedPacto, Inc. researches and develops anti-cancer drugs. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-12-19. The firm researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.

MedPacto Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-643.7%
=
Operating Income
₩-15.9B
/
Revenue
₩2.5B
What is MedPacto Inc's current Operating Margin?

The current Operating Margin for MedPacto Inc is -643.7%, which is above its 3-year median of -1 798.2%.

How has Operating Margin changed over time?

Over the last 6 months, MedPacto Inc’s Operating Margin has increased from -3 699.4% to -643.7%. During this period, it reached a low of -3 699.4% on Mar 31, 2025 and a high of -643.7% on Oct 30, 2025.

Back to Top